Featured Research

from universities, journals, and other organizations

New therapy potential lifesaver for those intolerant to blood thinners

Date:
January 14, 2014
Source:
Sanford Health
Summary:
A new, minimally invasive procedure for atrial fibrillation (AF) patients who are intolerant of blood-thinning medications is now available. Atrial fibrillation is a heart disorder that affects nearly 3 million adults in the United States. The procedure, which uses the FDA-approved LARIAT® Suture Delivery Device, provides a permanent, one-time solution to reduce complications surrounding the disorder -- primarily the risk of stroke.

Sanford Heart Hospitals in Fargo and Sioux Falls now provide a new, minimally invasive procedure for atrial fibrillation (AF) patients who are intolerant of blood-thinning medications. Atrial fibrillation is a heart disorder that affects nearly 3 million adults in the United States.

The procedure, which uses the FDA-approved LARIAT® Suture Delivery Device, provides a permanent, one-time solution to reduce complications surrounding the disorder -- primarily the risk of stroke. Sanford Heart Hospital locations are the only facilities in North Dakota and South Dakota to offer this therapy.

People with AF have an irregular heartbeat -- either too fast or too slow. The disruption makes it difficult for the heart's upper and lower chambers to work together, increasing the likelihood of blood to pool and dangerous clots to form.

Blood-thinning medications are an option, but approximately 40 percent of patients are intolerant to this form of therapy. Because people with AF are five times more likely to have a stroke -- most of which stem from blood clots in the heart's left atrial appendage (LAA) -- the experts at Sanford recognized a need.

Through a catheter procedure, cardiologists can close the LAA, blocking potential stroke-causing blood clots from traveling to the brain. Another benefit for the patients is that no metal, clip or implant are left behind.

"Atrial fibrillation patients who couldn't take blood thinning medications used to have very few options and were faced with a very real possibility of having a stroke," said Dr. Christopher Stanton, electrophysiologist at Sanford Heart Hospital in Sioux Falls. "We are proud to be the first in North Dakota and South Dakota to offer a permanent solution to reduce their risk."

Once the procedure is complete, patients no longer need to be on blood thinning medications. This also means patients will no longer need frequent medical visits and blood tests, which are required for those taking theses types of medications.

Sanford Health has successfully completed the first set of LARIAT® procedures in the Dakotas for patients who are at risk of stroke from AF and cannot take blood thinners.

"This procedure substantially reduces, but does not eliminate, the risk of stroke since 90 percent of thrombus originates within the left atrial appendage," said Fargo-based electrophysiologist Dr. Hung Kei-Li. "Moving forward, we will continue to strive for new and exciting technological advancements to improve the quality of life in patients with atrial fibrillation."


Story Source:

The above story is based on materials provided by Sanford Health. Note: Materials may be edited for content and length.


Cite This Page:

Sanford Health. "New therapy potential lifesaver for those intolerant to blood thinners." ScienceDaily. ScienceDaily, 14 January 2014. <www.sciencedaily.com/releases/2014/01/140114202657.htm>.
Sanford Health. (2014, January 14). New therapy potential lifesaver for those intolerant to blood thinners. ScienceDaily. Retrieved April 23, 2014 from www.sciencedaily.com/releases/2014/01/140114202657.htm
Sanford Health. "New therapy potential lifesaver for those intolerant to blood thinners." ScienceDaily. www.sciencedaily.com/releases/2014/01/140114202657.htm (accessed April 23, 2014).

Share This



More Health & Medicine News

Wednesday, April 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Big Pharma Braces for M&A Wave

Big Pharma Braces for M&A Wave

Reuters - Business Video Online (Apr. 22, 2014) — Big pharma on the move as Novartis boss, Joe Jimenez, tells Reuters about plans to transform his company via an asset exchange with GSK, and Astra Zeneca shares surge on speculation that Pfizer is looking for a takeover. Joanna Partridge reports. Video provided by Reuters
Powered by NewsLook.com
Study Says Most Crime Not Linked To Mental Illness

Study Says Most Crime Not Linked To Mental Illness

Newsy (Apr. 22, 2014) — A new study finds most crimes committed by people with mental illness are not caused by symptoms of their illness or disorder. Video provided by Newsy
Powered by NewsLook.com
Hagel Gets Preview of New High-Tech Projects

Hagel Gets Preview of New High-Tech Projects

AP (Apr. 22, 2014) — Defense Secretary Chuck Hagel is given hands-on demonstrations Tuesday of some of the newest research from DARPA _ the military's Defense Advanced Research Projects Agency program. (April 22) Video provided by AP
Powered by NewsLook.com
How Smaller Plates And Cutlery Could Make You Feel Fuller

How Smaller Plates And Cutlery Could Make You Feel Fuller

Newsy (Apr. 22, 2014) — NBC's "Today" conducted an experiment to see if changing the size of plates and utensils affects the amount individuals eat. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
 
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



    Save/Print:
    Share:  

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile iPhone Android Web
    Follow Facebook Twitter Google+
    Subscribe RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins